Table 7. Registered clinical trials on vaccines, Brazil, the Russian Federation, India, China and South Africa (BRICS), 2013.
| Country and reference | Number of registered trials in country |
Trials on new vaccine produced in country(% of any trials) | ||
|---|---|---|---|---|
| On any vaccine | On new vaccine | On new vaccine produced in country | ||
| Brazil34 | 49 | 46 | 8 | 16.3 |
| Russian Federation37 | 11 | 11 | 2 | 18.2 |
| India36 | 141 | 105 | 80 | 56.7 |
| China35 | 120 | 100 | 85 | 70.8 |
| South Africa38 | 50 | 38 | 0 | 0.0 |